Human IgG antibody Laboratories manufactures the tissue-tek oct compound reagents distributed by Genprice. The Tissue-Tek Oct Compound reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tissue tek oct. Other Tissue-Tek products are available in stock. Specificity: Tissue-Tek Category: Oct Group: Compound
Compound 2 |
|||
| HY-U00358 | MedChemExpress | 10mg | 6041 EUR |
Compound 34 |
|||
| GL2080-1MG | Glentham Life Sciences | 1 mg | 373 EUR |
Compound 34 |
|||
| GL2080-200UG | Glentham Life Sciences | 200 ug | 166 EUR |
Compound 112254 |
|||
| GL3740-10MG | Glentham Life Sciences | 10 mg | 166 EUR |
Compound 112254 |
|||
| GL3740-50MG | Glentham Life Sciences | 50 mg | 459 EUR |
Compound E |
|||
| GL3746-1MG | Glentham Life Sciences | 1 mg | 378 EUR |
Compound E |
|||
| GL3746-250UG | Glentham Life Sciences | 250 ug | 172 EUR |
Compound E |
|||
| GL3746-5MG | Glentham Life Sciences | 5 mg | 998 EUR |
Imidazoquinoline Compound |
|||
| VAdv-Ly0028 | Creative Biolabs | 5 mg | 3280 EUR |
|
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant. |
|||
Compound CL0485 |
|||
| ADC-P-074 | Creative Biolabs | unit | Ask for price |
Compound K |
|||
| N1890-20 | ApexBio | 20 mg | 340 EUR |
|
Description: Compound K |
|||
Compound 56 |
|||
| A8197-.5 | ApexBio | 500 µg | 108 EUR |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5 | ApexBio | 5 mg | 224 EUR |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 270 EUR |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-S | ApexBio | Evaluation Sample | 81 EUR |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 401 |
|||
| B7337-10 | ApexBio | 10 mg | 224 EUR |
Compound 401 |
|||
| B7337-25 | ApexBio | 25 mg | 441 EUR |